arrow
H

Hiroshi Watanabe

kumamoto university
H指数:58
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nivolumab for cancer of unknown primary (CUP): Clinical efficacy and biomarker analysis from NivoCUP2 expanded access program (WJOG14620M)

纳武利尤单抗用于未知原发灶癌症(CUP):来自纳武利尤单抗CUP2扩展性用药项目(WJOG14620M)的临床疗效与生物标志物分析

2024-09-010
PRE
Carbon monoxide-loaded cell therapy as an exercise mimetic for sarcopenia treatment

一氧化碳负载的细胞疗法作为肌肉减少症治疗的运动模拟物

2024-08-011
PRE
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer
2024-03-220
PRE
Docetaxel Plus Ramucirumab With Primary Prophylactic Pegylated Granulocyte-Colony Stimulating Factor Support for Elderly Patients With Advanced NSCLC: A Multicenter Prospective Single Arm Phase 2 Trial: DRAGON Study (WJOG9416L)
2023-10-011
OA
A multi-institutional prospective biomarker study of durvalumab after concurrent chemoradiation therapy in patients with unresectable stage III non-small cell lung cancer (WJOG11518L/SUBMARINE)
2023-04-040
PRE
Case report: Unusual development of hepatocellular carcinoma during immunosuppressive treatments against rheumatoid arthritis overlapping Sjogren's syndrome; cirrhotic steatohepatitis with liver inflammation and fibrosis lurks in autoimmune disorders
2023-02-151
OAAI